Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annu...(( this.href ); target _blank title Ch...)

Date:11/5/2009

( this.href );" target="_blank" title="Chicago Cornea Consultants">Chicago Cornea Consultants and Associate Professor of Ophthalmology at Rush University Medical Center in Chicago, was an active contributor at the AAO meeting in several capacities across various sub-specialties, including LASIK and other laser vision procedures as well as cataract surgery. He served as Invited Faculty at the "Cornea and Anterior Segment Disasters: Bringing Them back from the Precipice" meeting and was an invited instructor for the "LASIK Course". During 2009, Dr. Majmudar has served as Chairman of the AAO Refractive Surgery Subcommittee and as a member of the AAO Annual Meeting Program Committee. He is one of 4 international surgeons to be invited to the Annual Meeting of the Refractive Implant and IOL Society to be held in Agra, India in December 2009. Of special note, Dr. Majmudar was one of the first refractive surgeons in the United States to perform the Veriflex phakic implant procedures, which is used for patients with high myopia (nearsightedness) that cannot have LASIK, and helped pioneer the use of MMC, a drug used for the prevention and treatment of corneal scarring in association with certain refractive surgical procedures. Dr. Majmudar serves patients seeking LASIK Surgery and other vision correction procedures as well as cataract surgery is based in Chicago, Illinois.

Los Angeles LASIK Surgeon Dr. James J. Salz, CEO of Trusted LASIK Surgeons summarize the AAO meeting as follows: "the most impressive aspect of the AAO annual meeting is the continued advancements in high technology instruments. Speakers, including the many experts listed at Trusted LASIK Surgeon, as well as industry
'/>"/>

Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9
Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
3. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
4. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
5. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
6. Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
7. K-State Research Leading to Software to Help Nations Cattle Producers Identify Biosecurity Risks, Evaluate Impact of Cow-Calf Diseases Online
8. Leading Biotechnology Company Grows with StayinFront CRM
9. Leading Pharmaceutical Communication Executives Gather for the 1st Annual Pharmaceutical Public Relations Symposium
10. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
11. 2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies